{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T19:38:15Z","timestamp":1769197095661,"version":"3.49.0"},"reference-count":26,"publisher":"Becaris Publishing Limited","issue":"9","funder":[{"DOI":"10.13039\/100007497","name":"Biosense Webster","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007497","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Comp. Eff. Res."],"published-print":{"date-parts":[[2023,9]]},"abstract":"<jats:p>\n            <jats:bold>Aim:<\/jats:bold>\n            The objective of this study was to indirectly compare QDOT MICRO\u2122 (QDOT), Thermocool\n            <jats:sup>\u00ae<\/jats:sup>\n            SmartTouch\u2122 (ST)\u00a0and Thermocool\n            <jats:sup>\u00ae<\/jats:sup>\n            SmartTouch\n            <jats:sup>\u00ae<\/jats:sup>\n            Surround Flow (STSF) to treat paroxysmal atrial fibrillation.\n            <jats:bold>Methods:<\/jats:bold>\n            Differences in baseline characteristics between study cohorts were reduced by reweighting patients using inverse probability of treatment weighting. The primary outcome was procedure time. Secondary outcomes were fluoroscopy time, clinical success at 12\u00a0months, and rhythm monitoring-adjusted recurrence.\n            <jats:bold>Results:<\/jats:bold>\n            QDOT was associated with significantly faster mean procedure and fluoroscopy time, and significant improvement in the rate of recurrence compared with pooled ST\/STSF. No difference was observed for clinical success at 12\u00a0months.\n            <jats:bold>Conclusion:<\/jats:bold>\n            QDOT was associated with greater efficiency, greater effectiveness in rhythm monitoring-adjusted recurrence and similar effectiveness in clinical success at 12\u00a0months compared with pooled ST\/STSF.\n          <\/jats:p>","DOI":"10.57264\/cer-2023-0005","type":"journal-article","created":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T12:01:16Z","timestamp":1692187276000},"source":"Crossref","is-referenced-by-count":2,"title":["QDOT MICRO\u2122 versus THERMOCOOL\n            <sup>\u00ae<\/sup>\n            SMARTTOUCH\u2122 and THERMOCOOL SMARTTOUCH\n            <sup>\u00ae<\/sup>\n            Surround Flow in radiofrequency ablation of paroxysmal atrial fibrillation"],"prefix":"10.57264","volume":"12","author":[{"given":"Jose","family":"Osorio","sequence":"first","affiliation":[{"name":"Medical Director Electrophysiology, Electrophysiology - Cardiovascular Group, HCA Florida Miami, Miami, FL\u00a033133, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonia","family":"Maccioni","sequence":"additional","affiliation":[{"name":"Johnson &amp; Johnson Medical Devices, Franchise Health Economics and Market Access, Irvine, CA\u00a092618, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reecha","family":"Sharma","sequence":"additional","affiliation":[{"name":"Johnson &amp; Johnson Medical Devices, Clinical Research, Irvine, CA\u00a092618, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leena","family":"Patel","sequence":"additional","affiliation":[{"name":"EVERSANATM, Burlington, ON, L7N 3H8, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Spin","sequence":"additional","affiliation":[{"name":"EVERSANATM, Burlington, ON, L7N 3H8, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Natale","sequence":"additional","affiliation":[{"name":"Executive Medical Director, Texas Cardiac Arrhythmia Research, St. David's Medical Center, Austin, TX\u00a078705, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"36897","reference":[{"issue":"5","key":"e_1_3_7_3_2","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","article-title":"2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC","volume":"42","author":"Hindricks G","year":"2021","unstructured":"Hindricks G, Potpara T, Dagres N 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur. Heart J. 42(5), 373\u2013498 (2021).","journal-title":"Eur. Heart J."},{"issue":"2","key":"e_1_3_7_4_2","doi-asserted-by":"crossref","first-page":"e125","DOI":"10.1161\/CIR.0000000000000665","article-title":"2019 AHA\/ACC\/HRS Focused Update of the 2014 AHA\/ACC\/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons","volume":"140","author":"January CT","year":"2019","unstructured":"January CT, Wann LS, Calkins H 2019 AHA\/ACC\/HRS Focused Update of the 2014 AHA\/ACC\/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons. Circulation 140(2), e125\u2013e151 (2019).","journal-title":"Circulation"},{"key":"e_1_3_7_5_2","unstructured":"Biosense Webster Inc. Evaluation of QDOT MICRO\u2122 Catheter for Pulmonary Vein Isolation in Subjects With Paroxysmal Atrial Fibrillation (Q-FFICIENCY). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03775512 (8 April 2022)."},{"issue":"1","key":"e_1_3_7_6_2","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s10840-014-9947-2","article-title":"Catheter-tissue contact force values do not impact mid-term clinical outcome following pulmonary vein isolation in patients with paroxysmal atrial fibrillation","volume":"42","author":"Stabile G","year":"2015","unstructured":"Stabile G, Solimene F, Cal\u00f2 L Catheter-tissue contact force values do not impact mid-term clinical outcome following pulmonary vein isolation in patients with paroxysmal atrial fibrillation. J. Interv. Card. Electrophysiol. 42(1), 21\u201326 (2015).","journal-title":"J. Interv. Card. Electrophysiol."},{"issue":"7","key":"e_1_3_7_7_2","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.jacep.2019.04.009","article-title":"Pulmonary Vein Isolation With Very High Power, Short Duration, Temperature-Controlled Lesions: The QDOT-FAST Trial","volume":"5","author":"Reddy VY","year":"2019","unstructured":"Reddy VY, Grimaldi M, De Potter T Pulmonary Vein Isolation With Very High Power, Short Duration, Temperature-Controlled Lesions: The QDOT-FAST Trial. JACC Clin. Electrophysiol. 5(7), 778\u2013786 (2019).","journal-title":"JACC Clin. Electrophysiol."},{"key":"e_1_3_7_8_2","article-title":"Very high-power short-duration temperature-controlled ablation versus conventional power-controlled ablation for pulmonary vein isolation: the fast and furious - AF study","volume":"35","author":"Richard Tilz R","year":"2021","unstructured":"Richard Tilz R, Sano M, Vogler J Very high-power short-duration temperature-controlled ablation versus conventional power-controlled ablation for pulmonary vein isolation: the fast and furious - AF study. Int. J. Cardiol. Heart Vasc. 35, DOI: 10.1016\/j.ijcha.2021.100847 (2021).","journal-title":"Int. J. Cardiol. Heart Vasc."},{"issue":"4","key":"e_1_3_7_9_2","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.jacep.2022.10.019","article-title":"Very high-power short-duration, temperature-controlled radiofrequency ablation in paroxysmal atrial fibrillation: the prospective multicenter Q-FFICIENCY Trial","volume":"9","author":"Osorio J","year":"2023","unstructured":"Osorio J, Hussein AA, Delaughter MC for the Q-FFICIENCY Trial Investigators. Very high-power short-duration, temperature-controlled radiofrequency ablation in paroxysmal atrial fibrillation: the prospective multicenter Q-FFICIENCY Trial. JACC Clin. Electrophysiol. 9(4), 468\u2013480 (2023).","journal-title":"JACC Clin. Electrophysiol."},{"issue":"7","key":"e_1_3_7_10_2","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.jacc.2014.04.072","article-title":"Paroxysmal AF catheter ablation with a contact force sensing catheter: results of the prospective, multicenter SMART-AF trial","volume":"64","author":"Natale A","year":"2014","unstructured":"Natale A, Reddy VY, Monir G Paroxysmal AF catheter ablation with a contact force sensing catheter: results of the prospective, multicenter SMART-AF trial. J. Am. Coll. Cardiol. 64(7), 647\u2013656 (2014).","journal-title":"J. Am. Coll. Cardiol."},{"issue":"3","key":"e_1_3_7_11_2","doi-asserted-by":"crossref","first-page":"f392","DOI":"10.1093\/europace\/eux264","article-title":"Safety and efficiency of porous-tip contact-force catheter for drug-refractory symptomatic paroxysmal atrial fibrillation ablation: results from the SMART SF trial","volume":"20","author":"Chinitz LA","year":"2018","unstructured":"Chinitz LA, Melby DP, Marchlinski FE Safety and efficiency of porous-tip contact-force catheter for drug-refractory symptomatic paroxysmal atrial fibrillation ablation: results from the SMART SF trial. Europace 20(Fi_3), f392\u2013f400 (2018).","journal-title":"Europace"},{"issue":"521","key":"e_1_3_7_12_2","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1080\/01621459.2016.1260466","article-title":"Balancing covariates via propensity score weighting","volume":"113","author":"Li F","year":"2018","unstructured":"Li F, Morgan KL, Zaslavsky AM. Balancing covariates via propensity score weighting. J. Am. Stat. Assoc. 113(521), 390\u2013400 (2018).","journal-title":"J. Am. Stat. Assoc."},{"issue":"2","key":"e_1_3_7_13_2","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1177\/0272989X17725740","article-title":"Methods for population-adjusted indirect comparisons in health technology appraisal","volume":"38","author":"Phillippo DM","year":"2018","unstructured":"Phillippo DM, Ades AE, Dias S, Palmer S, Abrams KR, Welton NJ. Methods for population-adjusted indirect comparisons in health technology appraisal. Med. Decis. Making 38(2), 200\u2013211 (2018).","journal-title":"Med. Decis. Making"},{"issue":"1","key":"e_1_3_7_14_2","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1080\/00015385.2021.1939512","article-title":"Meta-analysis of high power short duration in atrial fibrillation ablation \u2013 a superior efficient ablation strategy","volume":"77","author":"Xu M","year":"2022","unstructured":"Xu M, Yang Y, Zhang D, Jiang W. Meta-analysis of high power short duration in atrial fibrillation ablation \u2013 a superior efficient ablation strategy. Acta Cardiol. 77(1), 14\u201332 (2022).","journal-title":"Acta Cardiol."},{"issue":"1","key":"e_1_3_7_15_2","doi-asserted-by":"crossref","first-page":"2","DOI":"10.5152\/AnatolJCardiol.2021.243","article-title":"Meta-analysis comparing outcomes of high-power short-duration and low-power long-duration radiofrequency ablation for atrial fibrillation","volume":"26","author":"Khanra D","year":"2022","unstructured":"Khanra D, Hamid A, Deshpande S Meta-analysis comparing outcomes of high-power short-duration and low-power long-duration radiofrequency ablation for atrial fibrillation. Anatol. J. Cardiol. 26(1), 2\u201314 (2022).","journal-title":"Anatol. J. Cardiol."},{"issue":"1","key":"e_1_3_7_16_2","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/pace.14407","article-title":"Outcome of high-power short-duration radiofrequency ablation in combination with half-normal saline irrigation for the treatment of atrial fibrillation","volume":"45","author":"Maan A","year":"2022","unstructured":"Maan A, Bode WD, Heist EK Outcome of high-power short-duration radiofrequency ablation in combination with half-normal saline irrigation for the treatment of atrial fibrillation. Pacing Clin. Electrophysiol. 45(1), 43\u201349 (2022).","journal-title":"Pacing Clin. Electrophysiol."},{"key":"e_1_3_7_17_2","article-title":"Efficacy and safety of high-power short-duration radiofrequency catheter ablation of atrial fibrillation","volume":"8","author":"Park JW","year":"2021","unstructured":"Park JW, Yang SY, Kim M Efficacy and safety of high-power short-duration radiofrequency catheter ablation of atrial fibrillation. Front. Cardiovasc. Med. 8, DOI: 10.3389\/fcvm.2021.709585 (2021).","journal-title":"Front. Cardiovasc. Med."},{"issue":"11","key":"e_1_3_7_18_2","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1111\/jce.13745","article-title":"Outcomes of paroxysmal atrial fibrillation ablation studies are affected more by study design and patient mix than ablation technique","volume":"29","author":"Ferreira-Martins J","year":"2018","unstructured":"Ferreira-Martins J, Howard J, Al-Khayatt B Outcomes of paroxysmal atrial fibrillation ablation studies are affected more by study design and patient mix than ablation technique. J. Cardiovasc. Electrophysiol. 29(11), 1471\u20131479 (2018).","journal-title":"J. Cardiovasc. Electrophysiol."},{"issue":"1","key":"e_1_3_7_19_2","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1161\/CIRCULATIONAHA.121.056109","article-title":"Influence of monitoring strategy on assessment of ablation success and postablation atrial fibrillation burden assessment: implications for practice and clinical trial design","volume":"145","author":"Aguilar M","year":"2022","unstructured":"Aguilar M, Macle L, Deyell MW Influence of monitoring strategy on assessment of ablation success and postablation atrial fibrillation burden assessment: implications for practice and clinical trial design. Circulation 145(1), 21\u201330 (2022).","journal-title":"Circulation"},{"issue":"12","key":"e_1_3_7_20_2","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/j.hrthm.2006.07.030","article-title":"Comparison of continuous versus intermittent monitoring of atrial arrhythmias","volume":"3","author":"Ziegler PD","year":"2006","unstructured":"Ziegler PD, Koehler JL, Mehra R. Comparison of continuous versus intermittent monitoring of atrial arrhythmias. Heart Rhythm 3(12), 1445\u20131452 (2006).","journal-title":"Heart Rhythm"},{"issue":"6","key":"e_1_3_7_21_2","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.jacc.2004.11.050","article-title":"Role of transtelephonic electrocardiographic monitoring in detecting short-term arrhythmia recurrences after radiofrequency ablation in patients with atrial fibrillation","volume":"45","author":"Senatore G","year":"2005","unstructured":"Senatore G, Stabile G, Bertaglia E Role of transtelephonic electrocardiographic monitoring in detecting short-term arrhythmia recurrences after radiofrequency ablation in patients with atrial fibrillation. J. Am. Coll. Cardiol. 45(6), 873\u2013876 (2005).","journal-title":"J. Am. Coll. Cardiol."},{"issue":"12","key":"e_1_3_7_22_2","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1111\/j.1540-8167.2005.00245.x","article-title":"Value of different follow-up strategies to assess the efficacy of circumferential pulmonary vein ablation for the curative treatment of atrial fibrillation","volume":"16","author":"Piorkowski C","year":"2005","unstructured":"Piorkowski C, Kottkamp H, Tanner H Value of different follow-up strategies to assess the efficacy of circumferential pulmonary vein ablation for the curative treatment of atrial fibrillation. J. Cardiovasc. Electrophysiol. 16(12), 1286\u20131292 (2005).","journal-title":"J. Cardiovasc. Electrophysiol."},{"issue":"3","key":"e_1_3_7_23_2","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.ijcard.2008.10.004","article-title":"Influence of the duration of Holter monitoring on the detection of arrhythmia recurrences after catheter ablation of atrial fibrillation: implications for patient follow-up","volume":"139","author":"Dagres N","year":"2010","unstructured":"Dagres N, Kottkamp H, Piorkowski C Influence of the duration of Holter monitoring on the detection of arrhythmia recurrences after catheter ablation of atrial fibrillation: implications for patient follow-up. Int. J. Cardiol. 139(3), 305\u2013306 (2010).","journal-title":"Int. J. Cardiol."},{"key":"e_1_3_7_24_2","volume-title":"The use of observational data to inform estimates of treatment effectiveness in technology appraisal: methods for comparative individual patient data: NICE DSU technical support document.","author":"Faria R","year":"2022","unstructured":"Faria R, Hernandez M, Manca A, Wailoo A. The use of observational data to inform estimates of treatment effectiveness in technology appraisal: methods for comparative individual patient data: NICE DSU technical support document. NICE, Sheffield, UK (2022). https:\/\/www.sheffield.ac.uk\/sites\/default\/files\/2022-02\/TSD17-DSU-Observational-data-FINAL.pdf"},{"issue":"3","key":"e_1_3_7_25_2","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/pace.14167","article-title":"High-power short-duration ablation of atrial fibrillation: a contemporary review","volume":"44","author":"Naniwadekar A","year":"2021","unstructured":"Naniwadekar A, Dukkipati SR. High-power short-duration ablation of atrial fibrillation: a contemporary review. Pacing Clin. Electrophysiol. 44(3), 528\u2013540 (2021).","journal-title":"Pacing Clin. Electrophysiol."},{"issue":"4","key":"e_1_3_7_26_2","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1002\/joa3.12592","article-title":"Novel concepts in atrial fibrillation ablation-breaking the trade-off between efficacy and safety","volume":"37","author":"Althoff TF","year":"2021","unstructured":"Althoff TF, Mont L. Novel concepts in atrial fibrillation ablation-breaking the trade-off between efficacy and safety. J. Arrhythm 37(4), 904\u2013911 (2021).","journal-title":"J. Arrhythm"},{"issue":"7","key":"e_1_3_7_27_2","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1093\/europace\/euu386","article-title":"Comparison of \u2018anatomically designed\u2019 and \u2018point-by-point\u2019 catheter ablations for human atrial fibrillation in terms of procedure timing and costs in German hospitals","volume":"17","author":"Klein G","year":"2015","unstructured":"Klein G, Lickfett L, Schreieck J Comparison of \u2018anatomically designed\u2019 and \u2018point-by-point\u2019 catheter ablations for human atrial fibrillation in terms of procedure timing and costs in German hospitals. Europace 17(7), 1030\u20131037 (2015).","journal-title":"Europace"},{"issue":"5","key":"e_1_3_7_28_2","first-page":"1775","article-title":"Anesthetic management in electrophysiology laboratory: a multidisciplinary review","volume":"10","author":"Yildiz M","year":"2018","unstructured":"Yildiz M, Yilmaz Ak H, Oksen D, Oral S. Anesthetic management in electrophysiology laboratory: a multidisciplinary review. J. Atr. Fibrillation 10(5), 1775 (2018).","journal-title":"J. Atr. Fibrillation"}],"container-title":["Journal of Comparative Effectiveness Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/becarispublishing.com\/doi\/pdf\/10.57264\/cer-2023-0005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T18:37:52Z","timestamp":1693507072000},"score":1,"resource":{"primary":{"URL":"https:\/\/becarispublishing.com\/doi\/10.57264\/cer-2023-0005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":26,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["10.57264\/cer-2023-0005"],"URL":"https:\/\/doi.org\/10.57264\/cer-2023-0005","relation":{},"ISSN":["2042-6305","2042-6313"],"issn-type":[{"value":"2042-6305","type":"print"},{"value":"2042-6313","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9]]},"article-number":"e230005"}}